Murashima Shiroh | Second Department Of Internal Medicine Kurume University School Of Medicine

スポンサーリンク

概要

関連著者

もっと見る

著作論文

Peginterferon-alpha-2b plus ribavirin therapy in patients with chronic hepatitis C as assessed by a multi-institutional questionnaire in Japan
Human primary cultured hepatic stellate cells can be cryopreserved
High expression of insulin-like growth factor binding protein-3 is correlated with lower portal invasion and better prognosis in human hepatocellular carcinoma
Case-control study for the identification of virological factors associated with fulminant hepatitis B
Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients
Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis
Periostin and bone marrow fibrosis
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
Keratin inclusions alter cytosolic protein localization in hepatocytes
Double filtration plasmapheresis and interferon combination therapy for chronic hepatitis C patients with genotype 1 and high viral load
Identification of new immunogenic peptides in conserved regions of hepatitis C virus (HCV) 1b with the potentiality to generate cytotoxic T lymphocytes in HCV1b^+ HLA-A24^+ patients
Impaired Filterability of Erythrocytes from Patients with Chronic Hepatitis C and Effects of Eicosapentaenoic Acid on the Filterability
New Epitope Peptides Derived from Hepatitis C Virus (HCV) 2a Which Have the Capacity to Induce Cytotoxic T Lymphocytes in HLA-A2^+ HCV-Infected Patients
Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Liposome-mediated gene transfer of K1-5 suppresses tumor development and improves the prognosis of hepatocellular carcinoma in mice
A case-control study of response to lamivudine therapy for 2 years in Japanese and Chinese patients chronically infected with hepatitis B virus of genotypes Bj, Ba and C
Angiogenic cell therapy for hepatic fibrosis
Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
A human T-cell lymphotropic virus type-1 (HTLV-1) carrier complicated with various autoimmune diseases including primary biliary cirrhosis
Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
Unusual hyperbilirubinemia associated with bacterial pneumonia and acute myeloid leukemia
Blastoid Variant of Mantle Cell Lymphoma with Lactic Acidosis : A Case Report
Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases
Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C
Bronchiolitis obliterans organizing pneumonia in a patient with primary biliary cirrhosis and rheumatoid arthritis treated with prednisolone
Systemic Sclerosis Associated with Diabetes Insipidus
Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
Prognostic indicators of breakthrough hepatitis during lamivudine monotherapy for chronic hepatitis B virus infection
Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene
Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
Hepatitis B virus genotype G is an extremely rare genotype in Japan
Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
Analysis of approach to therapy for chronic liver disease in an HCV hyperendemic area of Japan
Sequence Variation of the Hypervariable Region in HCV Carriers with Normal ALT Levels:A Comparison with Symptomatic Carriers
Phase I clinical study of a peptide vaccination for hepatitis C virus-infected patients with different human leukocyte antigen-class I-A alleles
Recent progress in the management of hepatocellular carcinoma detected during a surveillance program in Japan
Efficacy and safety of double filtration plasmapheresis in combination with interferon therapy for chronic hepatitis C
Hybrid training of voluntary and electrical muscle contractions reduces steatosis, insulin resistance, and IL-6 levels in patients with NAFLD : a pilot study
Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

もっと見る

スポンサーリンク